1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals in Mexico

Pharmaceuticals in Mexico

  • September 2016
  • -
  • MarketLine
  • -
  • 38 pages

Summary
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico

Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
What was the size of the Mexico pharmaceuticals market by value in 2015?

What will be the size of the Mexico pharmaceuticals market in 2020?

What factors are affecting the strength of competition in the Mexico pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitors in Mexico's pharmaceuticals market?

Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Mexican pharmaceuticals market had total revenues of $8.4bn in 2015, representing a compound annual growth rate (CAGR) of 1.3% between 2011 and 2015.

A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products in Mexico.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.2% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $9.3bn by the end of 2020.

Table Of Contents

Pharmaceuticals in Mexico
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Merck and Co., Inc.
Novartis AG
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Mexico pharmaceuticals market value: $ billion, 2011-15
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Mexico pharmaceuticals market share: % share, by value, 2015
Table 4: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Merck and Co., Inc.: key facts
Table 10: Merck and Co., Inc.: key financials ($)
Table 11: Merck and Co., Inc.: key financial ratios
Table 12: Novartis AG: key facts
Table 13: Novartis AG: key financials ($)
Table 14: Novartis AG: key financial ratios
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: key financials ($)
Table 17: Pfizer Inc.: key financial ratios
Table 18: Mexico size of population (million), 2011-15
Table 19: Mexico gdp (constant 2005 prices, $ billion), 2011-15
Table 20: Mexico gdp (current prices, $ billion), 2011-15
Table 21: Mexico inflation, 2011-15
Table 22: Mexico consumer price index (absolute), 2011-15
Table 23: Mexico exchange rate, 2011-15

List of Figures
Figure 1: Mexico pharmaceuticals market value: $ billion, 2011-15
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Mexico pharmaceuticals market share: % share, by value, 2015
Figure 4: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2015
Figure 11: Bayer AG: revenues and profitability
Figure 12: Bayer AG: assets and liabilities
Figure 13: Merck and Co., Inc.: revenues and profitability
Figure 14: Merck and Co., Inc.: assets and liabilities
Figure 15: Novartis AG: revenues and profitability
Figure 16: Novartis AG: assets and liabilities
Figure 17: Pfizer Inc.: revenues and profitability
Figure 18: Pfizer Inc.: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.